Bansi Desai
Stock Analyst at J.P. Morgan
(2.83)
# 2,817
Out of 5,126 analysts
76
Total ratings
43.5%
Success rate
3.9%
Average return
Main Sectors:
Stocks Rated by Bansi Desai
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NSE: ANTHEM Anthem Biosciences Limited | Reiterated: Buy | ₹900.00 → ₹1,000 | ₹957.90 | +4.40% | 5 | Nov 5, 2026 | |
| NSE: LUPIN Lupin Limited | Reiterated: Hold | ₹2,700 → ₹2,300 | ₹2,023 | +13.67% | 7 | Nov 5, 2026 | |
| NSE: ZYDUSLIFE Zydus Lifesciences Limited | Reiterated: Hold | ₹1,240 → ₹1,250 | ₹1,200 | +4.21% | 6 | Nov 5, 2026 | |
| NSE: DRREDDY Dr. Reddy's Laboratories Limited | Upgraded: Hold | ₹1,150 → ₹1,270 | ₹1,377 | -7.77% | 5 | Oct 25, 2026 | |
| NSE: ALKEM Alkem Laboratories Limited | Reiterated: Hold | ₹5,900 → ₹6,100 | ₹5,448 | +11.97% | 6 | Aug 17, 2026 | |
| NSE: FORTIS Fortis Healthcare Limited | Reiterated: Buy | ₹1,120 → ₹1,180 | ₹772.00 | +52.85% | 6 | Aug 10, 2026 | |
| NSE: DIVISLAB Divi's Laboratories Limited | Reiterated: Buy | ₹7,400 → ₹9,100 | ₹11,367 | -19.94% | 3 | Aug 4, 2026 | |
| NSE: MANKIND Mankind Pharma Limited | Downgraded: Hold | ₹2,850 → ₹2,700 | ₹2,660 | +1.50% | 7 | Aug 4, 2026 | |
| NSE: CIPLA Cipla Limited | Reiterated: Buy | ₹1,550 → ₹1,600 | ₹1,420 | +12.68% | 6 | Jul 28, 2026 | |
| NSE: BLUEJET Blue Jet Healthcare Limited | Reiterated: Sell | ₹600.00 → ₹370.00 | ₹535.10 | -30.85% | 4 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹34,500 → ₹37,000 | ₹26,130 | n/a | 5 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ₹1,350 → ₹1,550 | ₹2,235 | n/a | 3 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ₹1,240 → ₹1,480 | ₹1,430 | n/a | 2 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹2,030 → ₹1,970 | ₹1,902 | n/a | 4 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹1,700 → ₹1,840 | ₹1,281 | n/a | 4 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹1,390 → ₹1,325 | ₹928.30 | n/a | 2 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹8,800 | ₹8,604 | n/a | 1 | Feb 12, 2025 |
Anthem Biosciences Limited
Nov 5, 2026
Reiterated: Buy
Price Target: ₹900.00 → ₹1,000
Current: ₹957.90
Upside: +4.40%
Lupin Limited
Nov 5, 2026
Reiterated: Hold
Price Target: ₹2,700 → ₹2,300
Current: ₹2,023
Upside: +13.67%
Zydus Lifesciences Limited
Nov 5, 2026
Reiterated: Hold
Price Target: ₹1,240 → ₹1,250
Current: ₹1,200
Upside: +4.21%
Dr. Reddy's Laboratories Limited
Oct 25, 2026
Upgraded: Hold
Price Target: ₹1,150 → ₹1,270
Current: ₹1,377
Upside: -7.77%
Alkem Laboratories Limited
Aug 17, 2026
Reiterated: Hold
Price Target: ₹5,900 → ₹6,100
Current: ₹5,448
Upside: +11.97%
Fortis Healthcare Limited
Aug 10, 2026
Reiterated: Buy
Price Target: ₹1,120 → ₹1,180
Current: ₹772.00
Upside: +52.85%
Divi's Laboratories Limited
Aug 4, 2026
Reiterated: Buy
Price Target: ₹7,400 → ₹9,100
Current: ₹11,367
Upside: -19.94%
Mankind Pharma Limited
Aug 4, 2026
Downgraded: Hold
Price Target: ₹2,850 → ₹2,700
Current: ₹2,660
Upside: +1.50%
Cipla Limited
Jul 28, 2026
Reiterated: Buy
Price Target: ₹1,550 → ₹1,600
Current: ₹1,420
Upside: +12.68%
Blue Jet Healthcare Limited
May 27, 2026
Reiterated: Sell
Price Target: ₹600.00 → ₹370.00
Current: ₹535.10
Upside: -30.85%
Aug 15, 2025
Reiterated: Buy
Price Target: ₹34,500 → ₹37,000
Current: ₹26,130
Upside: n/a
Aug 11, 2025
Reiterated: Hold
Price Target: ₹1,350 → ₹1,550
Current: ₹2,235
Upside: n/a
Aug 11, 2025
Reiterated: Hold
Price Target: ₹1,240 → ₹1,480
Current: ₹1,430
Upside: n/a
Aug 1, 2025
Reiterated: Buy
Price Target: ₹2,030 → ₹1,970
Current: ₹1,902
Upside: n/a
Jul 29, 2025
Reiterated: Buy
Price Target: ₹1,700 → ₹1,840
Current: ₹1,281
Upside: n/a
May 22, 2025
Reiterated: Buy
Price Target: ₹1,390 → ₹1,325
Current: ₹928.30
Upside: n/a
Feb 12, 2025
Reiterated: Buy
Price Target: ₹8,800
Current: ₹8,604
Upside: n/a